Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.

BMC cancer - 5 Jun 2017

Won Daeyoun David, Lee Jae Im, Lee In Kyu, Oh Seong-Taek, Jung Eun Sun, Lee Sung Hak

Abstract excerpt

BACKGROUND: BRAF and KRAS mutations are well-established biomarkers in anti-EGFR therapy. However, the prognostic significance of these mutations is still being examined. We determined the prognostic value of BRAF and KRAS mutations in Korean colorectal cancer (CRC) patients. METHODS: From July 2010 to September 2013, 1096 patients who underwent surgery for CRC at Seoul St. Mary's Hospital were included in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to BRAF gene
Share to EGFR gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to KRAS gene

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 28583095
DOI: 10.1186/s12885-017-3381-7
PMCID: PMC5460473

Genes

BRAF
KRAS
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.PMID 28583095Read ↗

Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer.Semantic proximity Read ↗

Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II/III colorectal cancer: A retrospective study and meta-analysisSemantic proximity Read ↗

Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer.Semantic proximity Read ↗

Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.Semantic proximity Read ↗

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancerSemantic proximity Read ↗

BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable MutationSemantic proximity Read ↗

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.Semantic proximity Read ↗

Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer.Semantic proximity Read ↗

The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.Semantic proximity Read ↗

The association of clinicopathological features and survival in colorectal cancer patients with kras mutation status.Semantic proximity Read ↗

The Prognostic Utilities of DNA Mismatch Repair Status and KRAS and BRAF Mutation in Korean Colorectal Cancer Patients: The KASID Multicenter Study.Semantic proximity Read ↗

Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.